Table 2

Baseline lesion and procedural outcomes

Baseline QCACohort A
(n=72*)
Cohort B
(n=79)
Target vessel
 Left Anterior Decending artery (LAD)37 (51.4%)41 (51.9%)
 Circumflex artery (Cx)22 (30.6%)20 (25.3%)
 Right Coronary Artery (RCA)13 (18.1%)18 (22.8%)
ACC/AHA lesion classification
 Type A21 (29.2%)9 (11.4%)
 Type B126 (36.1%)44 (55.7%)
 Type B225 (34.7%)22 (28.8%)
 Type C0 (0.0%)4 (5.1%)
Reference vessel diameter (mm)2.67±0.342.74±0.34
Lesion length (mm)10.8±3.512.2±4.3
Procedural data n= 73 n= 79
Preprocedure antiplatelets
 Aspirin73 (100.0%)79 (100.0%)
 Ticagrelor or clopidogrel72 (98.6%)79 (100.0%)
 Other antithrombotic agent1 (1.4%)0 (0.0%)
Nominal scaffold diameter (mm)2.88±0.212.89±0.21
Nominal scaffold length (mm)18.1±0.7019.0±2.20
Predilatation73 (100.0%)79 (100.0%)
Postdilatation62 (84.9%)70 (88.6%)
Maximal postdilatation pressure (atm)17±417±5
Maximal postdilatation balloon diameter (mm)3.15±0.363.26±0.34
Antiplatelets at follow-up
 Aspirin73 (100.0%)78 (98.7%)
 Ticagrelor or clopidogrel73 (100.0%)79 (100.0%)
  • Baseline procedural outcome for patients included in the matched analysis. Values are n (%) or mean±SD.

  • *One preprocedure image was not available for analysis.

  • QCA, quantitative coronary arteriography.